Inventor

PITTS WILLIAM J

US46 patents

⚠️ This page may combine multiple inventors who share the name “PITTS WILLIAM J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PITTS WILLIAM J

BRISTOL MYERS SQUIBB CO

Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme

Purine inhibitors of phosphodiesterase (PDE) 7

1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Fused heterocyclic compounds and use thereof

Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7

Substituted isoxazole compounds

Compounds derived from an amine nucleus and pharmaceutical compositions comprising same

Aminotriazolopyridines as kinase inhibitors

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

Triazolyl-substituted pyridyl compounds useful as kinase inhibitors

Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7

Heterocycles that are inhibitors of IMPDH enzyme

Acyl guanidine compounds and use thereof

Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases

Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors

Heteroaryl substituted pyridyl compounds useful as kinase modulators

Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators

Aminotriazolopyridines as kinase inhibitors

Aminoimidazopyridazines as kinase inhibitors

Heterocyclic compounds useful as modulators of TNF alpha

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same

8H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Indazole carboxamides as kinase inhibitors

1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)

Heteroaryl substituted pyridyl compounds useful as kinase modulators

Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

Indazole carboxamides as kinase inhibitors

Aminopyrrolotriazines as kinase inhibitors

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

Heteroaryl substituted pyridyl compounds useful as kinase modulators

Fused heterocyclic compounds and use thereof

Fused heterocyclic compounds and use thereof

Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same

Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors

Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

DU PONT MERCK PHARMA

Prostaglandin synthase inhibitors

Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents

PITTS WILLIAM J

Substituted heterocyclic compounds

1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same

BRISTOL MEYERS SQUIBB PHARMA C

Integrin antagonists

DU PONT PHARM CO

Integrin inhibitor prodrugs

DYCKMAN ALARIC J

Substituted pyrazole compounds

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases